Miraculins Announces Private Placement Offering
2014年5月21日 - 7:30PM
Marketwired
Miraculins Announces Private Placement Offering
WINNIPEG, MANITOBA--(Marketwired - May 21, 2014) - Miraculins
Inc. (TSX-VENTURE:MOM), (the "Company"), a medical diagnostic
company focused on acquiring, developing and commercializing
diagnostic tests and risk assessment technologies for unmet
clinical needs, today announces a non-brokered private placement
offering (the "Offering") of up to 2,500,000 units ("Units") at a
price of $0.10 per Unit for gross proceeds of up to $250,000. Each
Unit will be comprised of one common share of the Company (a
"Share") and one Share purchase warrant. Each whole warrant (a
"Warrant") will entitle the holder to purchase one Share at a price
of $0.15 per Share for a period of 24 months from the date the
Warrant is issued.
Certain persons may assist the Company by introducing potential
subscribers for the Offering and, subject to compliance with
applicable legislation, will be entitled to receive a finder's fee,
payable in cash and share purchase warrants, as permitted by
law.
The net proceeds of the Offering will be used for general
corporate purposes.
It is anticipated that a director of the Company, Jim Mellon,
through an investment company that he controls, will subscribe for
1,450,000 Units for gross proceeds of $145,000. Another insider of
the Company is expected to subscribe for 50,000 Units for gross
proceeds of $5,000.
The Offering is subject to receipt of all necessary approvals,
including the approval of the TSX Venture Exchange.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Christopher J. MoreauPresident & CEOMiraculins
Inc.204-477-7599204-453-1546info@miraculins.comwww.miraculins.com
Miraculins Inc. (TSXV:MOM)
過去 株価チャート
から 8 2024 まで 9 2024
Miraculins Inc. (TSXV:MOM)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about (トロントベンチャー取引所): 0 recent articles
その他のMiraculins Inc.ニュース記事